Effect of a low glycemic index Mediterranean diet on non-alcoholic fatty liver disease. A randomized controlled clinici trial

Journal of Nutrition, Health and Aging

Volumn 21, Issue 4, 2017, Pages 404-412

  Misciagna, G ^a   del Pilar Diaz M ^c   Caramia, D V ^a   Bonfiglio, C ^a   Franco, I ^a   Noviello, M R ^b   Chiloiro, M ^b   Abbrescia, D I ^a   Mirizzi, A ^a   Tanzi, M ^a   Caruso, M G ^b   Correale, M ^b   Reddavide, R ^b   Inguaggiato, R ^b   Cisternino, A M ^b   Osella, Alberto Rubén ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) GGaslini   (Italy)

^c FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Hepatic steatosis; low glycemic index Mediterranean diet; Mediterranean diet

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; MALE; MEDITERRANEAN DIET; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BLOOD; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DOUBLE BLIND PROCEDURE; ITALY; LIFESTYLE; PHYSIOLOGY; QUESTIONNAIRE;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIET, MEDITERRANEAN; DOUBLE-BLIND METHOD; FEMALE; GLYCEMIC INDEX; HUMANS; INSULIN; ITALY; LIFE STYLE; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; SURVEYS AND QUESTIONNAIRES;

EID: 84989205082     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-016-0809-8     Document Type: Article

References (52)

1. Loria P, Adinolfi LE, Bellentani S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A Decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010; 42: 272–282.http://dx.doi.org/10.1016/j.dld.2010.01.021
2. Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005:42,44–52.http://dx.doi.org/10.1002/hep.20734
3. Kotronen A, Juurinen L, Hakkarainen A, et al. Liver fat is increased in type 2 diabetes patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. Diabetes Care 2008; 31: 165–169.http://dx.doi.org/10.2337/dc07-1463
4. Zoppini G, Fedeli U, Gennaro N, et al. Mortality from chronic liver diseases in diabetes. Am J Gastroenterol 2014; 109: 1020–1025. http://dx.doi.org/10.1038/ajg.2014.132
5. Angelico F, Del Ben M, Conti R, et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005; 90: 1578–1582. http://dx.doi.org/10.1210/jc.2004-1024
6. Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249–1253.http://dx.doi.org/10.1053/j.gastro.2011.06.061
7. Mahady SE & George J. Management of Nonalcoholic Steatohepatitis. Clin Liver Dis 2012; 16: 631–645. http://dx.doi.org/10.1016/j.cld.2012.05.003
8. Sofi F, Abbate R, Gensini GF, et al. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010; 92: 1189–1196.http://dx.doi.org/10.3945/ajcn.2010.29673
9. Galbete C, Toledo E, Toledo JB, et al. Mediterranean diet and cognitive function: the SUN project. J Nutr Health Aging 2015; 19: 305–312. http://dx.doi.org/10.1007/s12603-015-0441-z
10. Kontogianni MD, Tileli N, Margariti A, et al. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr 2014; 33: 678–683.http://dx.doi.org/10.1016/j.clnu.2013.08.014
11. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368: 1279–1290.http://dx.doi.org/10.1056/NEJMoa1200303
12. Kastorini CM, Milionis HJ, Esposito K, et al. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011; 57: 1299–1313.http://dx.doi.org/10.1016/j.jacc.2010.09.073
13. Salas-Salvadó J, Bulló M, Babio N, et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 2011; 34: 14–19.http://dx.doi.org/10.2337/dc10-1288
14. Cozzolongo R, Osella AR, Elba S, et al. Epidemiology of HCV infection in the general population: a survey in a southern Italian town. Am J Gastroenterol 2009; 104: 2740–2746.http://dx.doi.org/10.1038/ajg.2009.428
15. Nestle M. Mediterranean diets: historical and research overview. Am J Clin Nutr 1995;61:Suppl, S1313–S1320.
16. Chiloiro M, Caruso MG, Cisternino AM, et al. Ultrasound evaluation and correlates of fatty liver disease: A population Study in a Mediterranean Area. Metab Syndr Relat Disord 2013; 11: 349–358.http://dx.doi.org/10.1089/met.2012.0169
17. Skinner HA & Sheu WJ. Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Stud Alcohol 1982; 43: 1157–1170.
18. Chiloiro M, Misciagna G. (2012) Ultrasonographic Anthropometry: An Application to the Measurement of Liver and Abdominal Fat. In: Preedy VR, ed. Handbook of Anthropometry, Physical Measures of Human Form in Health and Disease. New York: Springer, pp 2227–2242.
19. INRAN (2003). Linee Guida per una sana alimentazione italiana. http://nut.entecra. it/649/Introduzione.html (accessed November 2013).
20. Alberti-Fidanza A, Fidanza F. Mediterranean Adequacy Index of Italian diets. Public Health Nutrition 2004; 7: 937–941.http://dx.doi.org/10.1079/PHN2004557
21. Oakes JM, Rossi PH. The measurement of SES in health research: current practice and steps toward a new approach. Soc Sci Med 2003; 56: 769–784.http://dx.doi. org/10.1016/S0277-9536(02)00073-4
22. Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology 2006;6:33 http://dx.doi.org/10.1186/1471-230X-6-33
23. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13–22.
24. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722–728.http://dx.doi. org/10.7326/0003-4819-143-10-200511150-00009
25. Bedogni G, Bellentani S. Fatty liver disease: how frequent is it and why? Ann Hepatol 2004; 3: 63–65.
26. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450–455.http://dx.doi. org/10.1016/S0002-9343(99)00271-5
27. Shah K, Stufflebam A, Hilton TN, et al. Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity 2009; 17: 2162–2168.http://dx.doi.org/10.1038/oby.2009.126
28. Luyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998; 22: 222–226.
29. Katan MB. Weight-loss diets for the prevention and treatment of obesity. N Engl J Med 2009; 360: 923–925.http://dx.doi.org/10.1056/NEJMe0810291
30. Inguaggiato R, Ferrara P. (2012) Alimenti della Dieta Mediterranea. In: Cisternino AM, Misciagna G, ed. La Dieta Mediterranea della Puglia. Bari (Italy): Tholos, pp 151–185.
31. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a metaanalysis. Am J Clin Nutr 1998;67:577S–582S.
32. Hussein O, Grosovski M, Lasri E, et al. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol 2007; 13: 361–368.http://dx.doi.org/10.3748/wjg.v13.i3.361
33. Storlien LH, Kraegen EW, Chisholm DJ, et al. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987; 237: 885–888.http://dx.doi. org/10.1126/science.3303333
34. Levy JR, Clore JN, Stevens W. Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats. Hepatology 2004; 39: 608–616.http://dx.doi.org/10.1002/hep.20093
35. Sekiya M, Yahagi N, Matsuzaka T, et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003; 38: 1529–1539.http://dx.doi.org/10.1016/j.hep.2003.09.028
36. Cortez-Pinto H, Jesus L, Barros H, et al. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr 2006; 25: 816–823.http://dx.doi. org/10.1016/j.clnu.2006.01.027
37. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 2007; 47: 711–717. http://dx.doi.org/10.1016/j.jhep.2007.06.020
38. Capanni M, Calella F, Biagini MR, et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 2006; 23: 1143–1151.http://dx.doi. org/10.1111/j.1365-2036.2006.02885.x
39. Tanaka N, Sano K, Horiuchi A, et al. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 2008; 42: 413–418.http://dx.doi.org/10.1097/MCG.0b013e31815591aa
40. Omara-Alwala TR, Mebrahtu T, Prior DE, et al. Omega-three fatty acids in purslane (Portulaca oleracea) Tissues. J Am Oil Chem Soc 1991; 68: 198–199.http://dx.doi. org/10.1007/BF02657769
41. Westerbacka J, Lammi K, Häkkinen AM, et al. Dietary fat content modifies liver fat in overweight non-diabetic subjects. J Clin Endocrinol Metab 2005; 90: 2804–2809. http://dx.doi.org/10.1210/jc.2004-1983
42. van Herpen NA, Schrauwen-Hinderling VB, Schaart G, et al. Three weeks on a highfat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy overweight men. J Clin Endocrinol Metab 2011;96:E691–E695.http://dx.doi.org/10.1210/jc.2010-2243
43. Utzschneider KM, Bayer-Carter JL, Arbuckle MD, et al. Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycemic index diet to reduce liver fat in older subjects. Br J Nutr 2013; 109: 1096–1104.
44. Day CP & James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology 1998; 114: 842–845. http://dx.doi.org/10.1016/S0016-5085(98)70599-2
45. Alberti A, Fruttini D, Fidanza F. The Mediterranean Adequacy Index: further confirming results of validity. Nutr Metab Cardiovasc Dis 2009; 19: 61–66.http://dx.doi.org/10.1016/j.numecd.2007.11.008
46. Middleton G, Keegan R, Smith MF, et al. Implementing a Mediterranean Diet Intervention into an RCT: Lessons Learned from a Non-Mediterranean Based Country. J Nutr Health Aging2015; 19: 1019–1022. http://dx.doi.org/10.1007/s12603-015-0522-z.
47. Montori VM and Guyatt GH. Intention-to-treat principle. CMAJ 2001; 165: 1339–1341.
48. Joy D, Thava VR, Scott B. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539–543.http://dx.doi.org/10.1097/01. meg.0000059112.41030.2e
49. Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007; 46: 582–589.http://dx.doi.org/10.1002/hep.21768
50. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745–750.http://dx.doi. org/10.1053/gast.2002.35354
51. Cameron SV & Heckman JJ. Life Cycle Schooling and Dynamic Selection Bias: Models and Evidence for Five Cohorts of American Males. The Journal of Political Economy 1998;106:262–333.
52. Bazzano LA, Hu T, Reynoldas K, et al. Effects of Low-Carbohydrate and Low-Fat Diets: A Randomized Trial. Ann Intern Med 2014; 161: 309–318.http://dx.doi. org/10.3390/nu7095377